Published June 24, 2023 | Version v1
Journal article Open

Supplementary tables

Authors/Creators

  • 1. LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
  • 2. Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark
  • 3. RefLab ApS, Copenhagen, Denmark
  • 4. Urticaria Center of Reference and Excellence (UCARE), Department of Dermatology and Venerology, Aarhus University Hospital, Aarhus, Denmark
  • 5. Urticaria Center of Reference and Excellence (UCARE), Institute of Allergology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Description

Supplementary material for article published in Clinical Experimental Allergy:
Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria

Files

Supplementary Tables.pdf

Files (188.7 kB)

Name Size Download all
md5:70a9d3d5b65261e96226c3d6a0305067
188.7 kB Preview Download